Researchers Targeting Tau Aggregates to Combat Alzheimer’s disease

Researchers Targeting Tau Aggregates to Combat Alzheimer’s disease
A team of researchers at VIB, KU Leuven and Janssen Pharmaceutica found that the presence of insoluble Tau protein aggregates, a typical characteristic of the brain in patients with Alzheimer’s disease, is facilitated by synaptic connections between brain cells. These findings offer the potential for the development of therapeutics to repair synaptic connections. Dieder Moechars (Janssen Pharmaceutica) said in a recent news release: "Looking at our results, we would advise caution regarding the therapeutic approach to the repair of synapses. Our research suggests that synapses also promote the distribution of Tau aggregates, which could counteract the positive effects of a repaired synapse. It is also important to take this into account when developing new therapeutic strategies, for example by combining a synapse restoring approach with one that would remove the Tau aggregate at the synapse." Patrik Verstreken (VIB/KU Leuven) added, "We have set up a new in vitro system specifically for this research, to enable us to study the distribution throughout the brain of aggregate proteins that are typical of neurodegenerative diseases. We also want to use this system to explore which substances could counteract the progress of neurodegeneration in the brain without having to use animal models at this early stage. This could become an important tool in the search for potential drugs against, for example, Alzheimer's disease.' Synaptic connections are essential for the proper function of brain cells. In Alzheimer's disease, t
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *